Mucosal Healing Predicts the Long-Term Prognosis of Intestinal Behçet’s Disease
暂无分享,去创建一个
[1] J. Cheon,et al. The Medical Treatments of Intestinal Behçet's Disease: An Update , 2013 .
[2] M. Neurath,et al. Mucosal healing in inflammatory bowel diseases: a systematic review , 2012, Gut.
[3] P. Rutgeerts,et al. Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. , 2012, Gastroenterology.
[4] E. Kuipers,et al. Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation , 2011, Inflammatory bowel diseases.
[5] P. Rutgeerts,et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. , 2011, Gastroenterology.
[6] Young Sook Park,et al. Development, validation, and responsiveness of a novel disease activity index for intestinal Behcet's disease , 2011, Inflammatory bowel diseases.
[7] M. Allez,et al. Role of endoscopy in predicting the disease course in inflammatory bowel disease. , 2010, World journal of gastroenterology.
[8] P. Rutgeerts,et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. , 2010, The New England journal of medicine.
[9] P. Rutgeerts,et al. Mucosal healing and anti TNFs in IBD. , 2010, Current drug targets.
[10] L. Peyrin-Biroulet,et al. Clinical implications of mucosal healing for the management of IBD , 2010, Nature Reviews Gastroenterology &Hepatology.
[11] Philippe Marteau,et al. Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease , 2009, Inflammatory bowel diseases.
[12] Eun Soo Kim,et al. Development and Validation of Novel Diagnostic Criteria for Intestinal Behçet's Disease in Korean Patients With Ileocolonic Ulcers , 2009, The American Journal of Gastroenterology.
[13] P. Rutgeerts,et al. Mucosal healing predicts long‐term outcome of maintenance therapy with infliximab in Crohn's disease , 2009, Inflammatory bowel diseases.
[14] K. Petraki,et al. Azathioprine Is Superior to Budesonide in Achieving and Maintaining Mucosal Healing and Histologic Remission in Steroid‐Dependent Crohn's Disease , 2009, Inflammatory bowel diseases.
[15] E. Ebert. Gastrointestinal Manifestations of Behçet’s Disease , 2009, Digestive Diseases and Sciences.
[16] J. Cheon,et al. Recent advances of endoscopy in inflammatory bowel diseases. , 2007, Gut and liver.
[17] Philippe Marteau,et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. , 2007, Gastroenterology.
[18] A. Moss,et al. Infliximab for induction and maintenance therapy for ulcerative colitis. , 2006, Gastroenterology.
[19] M. Bala,et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease , 2006 .
[20] G. Porro,et al. A rare cause of diuretic refractory ascites , 2005, Gut.
[21] Y. Cho,et al. Colonoscopic Findings in Intestinal Behçet's Disease , 2001, Inflammatory bowel diseases.
[22] I. Choi,et al. Prediction of the clinical course of Behçet's colitis according to macroscopic classification by colonoscopy. , 2000, Endoscopy.
[23] D. V. van Thiel,et al. Gastrointestinal manifestations of Behcet's disease. , 2000, Journal of clinical gastroenterology.
[24] O. Ozcebe,et al. Behçet's disease. , 2019, The New England journal of medicine.
[25] P. Rutgeerts,et al. Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine. , 1999, Gastrointestinal endoscopy.
[26] Shigeru Tanaka,et al. Intestinal involvement in Behçet's disease: Review of 136 surgical cases in the Japanese literature , 1981, Diseases of the colon and rectum.
[27] D. James. Behcet's syndrome. , 1979, The New England journal of medicine.
[28] M. Maruta,et al. Intestinal Behçet's disease: Report of five cases , 1976, Diseases of the colon and rectum.